Son güncelleme :
08/05/2024
Anti-kanama   Tranexamic acid  
Enjeksiyon
Oral solüsyon / oral çözelti
Çözeltilerin stabilitesi Karışımlardaki stabilitesi Stabiliteyi etkileyen faktörler Uyumluluk Uygulama yöntemi Kaynaklar Pdf
   Kimyasal yapı   

Ticari isim   Ticari isim     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acido tranexomico Ekvador, İtalya, Peru, Şili
Amchafibrin İspanya
Anvitoff Almanya
Arotran Arjantin
Beldex Mısır
Caprilon Finlandiya
Ciclokan Venezuela
Ciclokapron Almanya, Amerika Birleşik Devletleri, Avusturya, Büyük Britanya, Danimarka, Hollanda, İrlanda, İsveç, İsviçre, Kanada, Norveç, Şili, Suudi Arabistan, Venezuela, Yeni Zelanda
Dubatran Hindistan
Espercil Şili
Exacyl Belçika, Birleşik Arap Emirlikleri, Fas, Fransa, Lüksemburg, Polonya, Romanya
Examic Hindistan
Hemiblock Brezilya
Hemoblock Ekvador
Hemotran Peru
Hemoxamine Mısır
Kapron Mısır
Rixam Peru
Tranex İtalya
Tranexam Ekvador, Kolombiya
Tranexamic acid Amerika Birleşik Devletleri, Büyük Britanya, Kanada
Tranexol Peru
Tranexpalm Peru
Transamin Brezilya, Peru, Yunanistan
Transamine Türkiye
Traxenal Arjantin
Trexanic Şili
Ugorol İtalya
Velotin Şili
Xamic Hindistan, Şili
Kaynaklar   Enjeksiyon    Kaynaklar : Tranexamic acid  
Tip Yayın
1847 Dergi Anacardo R, Perilli O, Bartolini S, Gentile MM, Mazzeo P, Carlucci G.
Physicochemical compatibility between ketoprofen kysine salt injections (Artrosilene®) and pharmaceutical products frequently used for combined therapy by intravenous administration.
J Pharm Biomed Anal 2003 ; 32, 6: 1235-1241.
3728 Dergi Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.
Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3756 Dergi McCluskey S.V, Sztajnkrycer M.D, Jenkins D.A, Zietlow S P, Berns K.S, Park Myung S.
Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers.
Int J Pharm Compound 2014 ; 18, 5: 423-437.
3824 Dergi Boudi S, Roy H, Forest JM, Leclair G.
Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y.
Pharmactuel 2023 2023;56,3:91-98
3976 Dergi Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
4389 Dergi Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Pharmactuel 2019 ;52,4:206-213
4558 Dergi Studer, N.M, Yassin, A.H, Keen, D.E.
Compatibility of Hydroxyethyl Starch and Tranexamic Acid for Battlefield Co-Administration.
Milit Med 2016 ; 181, 10:1305.
4654 Afiş Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R.
Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables.
Communication personnelle 2021

  Mentions Légales